Expertise in
9
conditions

Liora Lazar

Tel Aviv, TA, IL 
Expertise in
9
conditions
Tel Aviv, TA, IL 

Overview

Liora Lazar practices practicing medicine in Tel Aviv, Israel.

Ms. Lazar is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Precocious Puberty, Idiopathic Short Stature (ISS), Diabetic Ketoacidosis, Type 1 Diabetes (T1D), and Thyroidectomy.

She is actively involved in clinical research, co-authoring 55 peer reviewed articles and participating in 14 clinical trials.

Gender

Female

Locations

Tel Aviv, TA, Israel
Other Locations
Petah Tiqwa, M, Israel
Jaffa, TA 69978, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Double Blind, Randomized, Placebo Controlled Pilot Study to Evaluate the Effect of Nutritional Supplementation on Physical Activity Performance of Young Soccer Players
Double Blind, Randomized, Placebo Controlled Pilot Study to Evaluate the Effect of Nutritional Supplementation on Physical Activity Performance of Young Soccer Players
Enrollment Status: Unknown
Publish Date: March 15, 2024
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Enrollment Status: Completed
Publish Date: February 22, 2022
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study
Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study
Enrollment Status: Terminated
Publish Date: December 01, 2020
Intervention Type: Device
Study Phase: Not Applicable
Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail
Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail
Enrollment Status: Completed
Publish Date: January 02, 2020
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
Enrollment Status: Withdrawn
Publish Date: December 30, 2019
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- Open Label, Parallel , Randomized, Controlled Multicenter Study-The Advice4U Pro Study
Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- Open Label, Parallel , Randomized, Controlled Multicenter Study-The Advice4U Pro Study
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device, Other
Study Phase: Not Applicable
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device
Study Phase: Not Applicable
Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility Study
Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility Study
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

55 Total Publications

Second Primary Malignancies Among Pediatric and Young Adult Survivors of Differentiated Thyroid Cancer: Real-World Evidence.
Second Primary Malignancies Among Pediatric and Young Adult Survivors of Differentiated Thyroid Cancer: Real-World Evidence.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 17, 2026

Frequently Asked Questions about Liora Lazar

Is Liora Lazar a top-rated expert for Precocious Puberty?

MediFind is an objective health platform that identifies experts based on real-world data. Liora Lazar is classified as an Elite expert for Precocious Puberty, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Liora Lazar participate in research or clinical trials?

Yes. Liora Lazar has published 55 articles and abstracts on conditions like Precocious Puberty. You can view a list of Liora Lazar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lazar's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile